Poly Medicure Ltd (POLYMED) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Poly Medicure Ltd on NSE and BSE, with an AI summary of each filing.
Intimation of earnings call on Financial Results for the Quarter and Half -Year ended on September 30, 2026
Intimation · 05 Nov 2026, 5:00 pm
Poly Medicure Schedules Q2FY27 and H1FY27 Earnings Conference Call Poly Medicure Limited will host its earnings conference call on 5th Nov'26 at 5:00 PM IST to discuss the unaudited financial results for the quarter and half-year ended 30th Sep'26 (Q2FY27). The company will be represented by Managing Director Himanshu Baid, Chief Financial Officer Naresh Vijayvergiya, and President of Strategy & Corporate Development Rahul Gautam. Universal dial-in access numbers for the call are +91 22 6280 1488 and +91 22 7115 8869.
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 05 Nov 2026, 5:30 am
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve a. The Unaudited Financial Results ....
Intimation · 05 Nov 2026, 5:30 am
Poly Medicure Schedules Board Meeting on 5th Nov'26 for Q2 Results Poly Medicure Limited has scheduled a meeting of its Board of Directors on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in the company's securities remains closed until 7th Nov'26.
Enclosed
Intimation · 24 Sept 2026, 10:42 pm
Poly Medicure Schedules Investor Plant Visit with Avendus Spark Poly Medicure Limited announced a one-on-one investor meeting and plant visit with Avendus Spark scheduled for 30th Sep'26 at 10:00 AM. The interaction will take place at the company's facility located in Sector-59, HSIIDC Industrial Area, Ballabhgarh, Faridabad, Haryana. As per the regulatory filing under SEBI LODR Regulations, the schedule remains subject to changes due to exigencies, and no unpublished price sensitive information (UPSI) will be shared during the meeting.
Enclosed
Intimation · 24 Sept 2026, 12:25 am
Poly Medicure Schedules One-on-One Investor Interaction with DAM Capital Poly Medicure Limited has scheduled a virtual one-on-one investor meeting with DAM Capital on 25th Sep'26 at 11:00 AM. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the company confirmed that no unpublished price-sensitive information (UPSI) will be shared during the interaction.
Enclosed
Intimation · 22 Sept 2026, 12:20 am
Poly Medicure Schedules One-on-One Investor Meeting with ICICI Securities PMS Poly Medicure Limited announced that company officials will host a physical, one-on-one meeting with ICICI Securities PMS on 24th Sep'26 at 04:00 PM. The interaction will take place at the company's registered office in Okhla Industrial Estate, New Delhi. Poly Medicure confirmed that no unpublished price-sensitive information (UPSI) will be shared during the session.
Enclosed
Intimation · 18 Sept 2026, 11:01 pm
Poly Medicure Schedules One-on-One Investor Meeting with Axis Max Life Poly Medicure Limited announced that its officials will participate in a virtual one-on-one investor meeting with Axis Max Life on 23rd Sep'26 at 04:00 PM. The interaction is scheduled pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting.
Scrutinizer Report and Voting Results
Annual General Meeting · 08 Sept 2026, 1:08 am
Poly Medicure Shareholders Approve All 31st AGM Resolutions with Requisite Majority Poly Medicure Limited announced that shareholders approved all five resolutions at its 31st AGM held on 5th Sep'26. Key approvals include the adoption of FY26 standalone and consolidated financial statements (99.9999% in favor), declaration of equity dividend for FY26 (99.9982% in favor), re-appointment of Mr. Rishi Baid as director (99.2029% in favor), re-appointment of Mr. Devendra Raj Mehta as Non-Executive Non-Independent Director via special resolution (99.0791% in favor), and remuneration approval for Cost Auditor M/s Jai Prakash & Company for FY27 (99.9999% in favor). Total voter turnout stood at ~85.87%.
Outcome of the 31st Annual General Meeting of the Poly Medicure Limited.
Annual General Meeting · 05 Sept 2026, 10:50 pm
Enclosed
Intimation · 02 Sept 2026, 9:53 pm
Poly Medicure Schedules One-on-One Meet with Sumitomo Mitsui Poly Medicure will host a one-on-one investor meeting with Sumitomo Mitsui DS Asset Management on 8th Sep'26 at 09:30 AM at its New Delhi registered office. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during the engagement.
Enclosed
Intimation · 26 Aug 2026, 4:21 am
Poly Medicure Reschedules Investor Meeting with Wasatch Global Poly Medicure (POLYMED) has rescheduled its one-on-one virtual investor meeting with Wasatch Global. The meeting, originally scheduled for 20th Aug'26, will now take place on 27th Aug'26 at 06:30 PM Indian Time. The venue (virtual) and format (one-on-one) remain unchanged. The company has stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during the call. This notice was filed with exchanges on 25th Aug'26.
Enclosed
Intimation · 22 Aug 2026, 9:07 pm
Poly Medicure Schedules Investor Meetings with Bandhan AMC and Sparx Capital Poly Medicure has scheduled one-on-one meetings with analysts and investors. A virtual meeting with Bandhan AMC will take place on 27th Aug'26, and an in-person meeting with Sparx Capital is set for 31st Aug'26. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions. The schedule is subject to change.
Enclosed
Intimation · 20 Aug 2026, 11:47 pm
Poly Medicure Cancels One-on-One Investor Meeting with Wasatch Global Poly Medicure has cancelled its scheduled one-to-one virtual meeting with investor Wasatch Global, which was set for 20th Aug'26. The cancellation was attributed to exigencies on the part of the analysts, investors, or the company. This update follows the initial meeting announcement made on 17th Aug'26.
Enclosed
Intimation · 17 Aug 2026, 11:46 pm
Poly Medicure Schedules Virtual One-on-One Investor Meetings Poly Medicure (POLYMED) will hold virtual one-on-one meetings with two investors on 20th Aug'26. The company is scheduled to meet with Bajaj Alternative Investment Ltd. at 12:00 PM and Wasatch Global at 06:30 PM India Time. Poly Medicure has stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these sessions. The schedule is subject to change based on exigencies. This intimation was filed on 17th Aug'26.
Enclosed
Transcript · 15 Aug 2026, 3:17 am
Poly Medicure Q1FY27: Strong Margins and Cautious Optimism Amid Headwinds Poly Medicure reported Q1FY27 consolidated revenue of INR525 crores (+30.3% YoY), including INR72.3 crores from acquisitions. Organic growth was 12.4%. Consolidated EBITDA stood at INR126.7 crores (+17.7%) with a 24.1% margin. Europe grew 17.6% organically, but Middle East business was down 32% due to geopolitical issues. Management maintained FY27 revenue guidance of INR2,300-2,400 crores with an EBITDA margin of 23-25%. A strategic plan, "PolyMed 3.0", aims to double revenue by FY30 through organic and inorganic expansion.
Enclosed
Annual Report · 15 Aug 2026, 2:59 am
Enclosed
Dividend · 15 Aug 2026, 1:37 am
Poly Medicure Announces Final Dividend for FY26 Poly Medicure has declared a final dividend of ₹3.50 per equity share (face value ₹5) for FY 2025-26, subject to shareholder approval. The company has fixed Saturday, 29th Aug'26 as the record date to determine shareholder eligibility. The book closure period is from 30th Aug'26 to 05th Sep'26. The dividend will be approved at the Annual General Meeting scheduled for Saturday, 05th Sep'26.
Record Date/ Book Closure Date
Dividend · 15 Aug 2026, 1:33 am
Poly Medicure Announces FY26 Final Dividend and Record Date Poly Medicure has declared a final dividend of ₹3.50 per equity share (face value ₹5) for FY 2025-26, subject to shareholder approval. The company has set Sat, 29th Aug'26 as the record date for determining shareholder eligibility. The book closure period will be from Sun, 30th Aug'26 to Sat, 5th Sep'26. The dividend proposal will be presented for approval at the Annual General Meeting, which is scheduled to be held on Sat, 5th Sep'26.
Enclosed
Annual General Meeting · 15 Aug 2026, 1:06 am
Poly Medicure AGM, FY26 Dividend, and Mandatory KYC Update Poly Medicure has scheduled its 31st AGM via VC on 05 Sep'26. The board proposed a final dividend of ₹3.50 per share (70%) for FY26, subject to shareholder approval. Per a SEBI circular, dividend payments are now electronic only. Shareholders, especially those holding physical shares, must update their PAN, bank details, and other KYC information with the RTA to receive dividends. The FY26 Annual Report and AGM notice are being dispatched to shareholders with registered emails.
Enclosed
Others (Uncategorized) · 15 Aug 2026, 12:55 am
Polymed's FY26 BRSR Highlights ESG Commitments and Product Mix Poly Medicure's FY26 BRSR, filed on 14th Aug'26, details its product mix and sustainability goals. The company's main business is manufacturing medical devices, with Infusion Therapy contributing 69.87% of turnover. Exports accounted for 65.01% of total turnover. As of Mar'26, Polymed had 1,553 employees and 4,260 workers. Key sustainability targets for FY26 include achieving Net Zero by 2050, reducing Scope 2 intensity by 40% by 2030, and sourcing 30% of energy from renewables by 2030. In FY26, renewable energy constituted ~10% of total electricity consumption.
Enclosed
Annual General Meeting · 15 Aug 2026, 12:11 am
Poly Medicure to Hold 31st AGM and Consider Final Dividend Poly Medicure has scheduled its 31st Annual General Meeting (AGM) for 5th Sep'26 at 11:00 A.M. (IST) via video conference. The board proposes a final dividend of ₹3.50 per equity share (face value ₹5) for the year ended 31st Mar'26, subject to shareholder approval. Key agenda items include adopting the FY26 financial statements and the re-appointment of Mr. Rishi Baid as Executive Director. The record date for dividend eligibility is 29th Aug'26, with remote e-voting open from 2nd Sep'26 to 4th Sep'26.
Enclosed
Audio / Video · 11 Aug 2026, 12:34 am
Poly Medicure Publishes Audio Recording of Q1 FY27 Earnings Call Poly Medicure has made the audio recording of its Earnings Conference Call available on its website. The call, held on 10 Aug'26, discussed the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. The disclosure was made in compliance with SEBI's Listing Obligations and Disclosure Requirements regulations.
enclosed
Others (Uncategorized) · 10 Aug 2026, 11:01 pm
Poly Medicure Reports QIP Fund Utilization with No Deviation Poly Medicure reports no deviation in the utilization of its Qualified Institutions Placement (QIP) funds for the quarter ended 30 Jun'26. The company raised approx. ₹100,000 lakh on 22 Aug'24. As of 30 Jun'26, it has utilized ₹52,021.92 lakh. Key allocations include ₹8,117.62 lakh for capital expenditure (out of ₹49,973.16 lakh), ₹25,026.84 lakh for inorganic initiatives, and ₹18,877.46 lakh for general corporate purposes. The Audit Committee reviewed the utilization and found no variations from the stated objectives.